Chaves-Ferreira Miguel, Albuquerque Inês S, Matak-Vinkovic Dijana, Coelho Ana C, Carvalho Sandra M, Saraiva Lígia M, Romão Carlos C, Bernardes Gonçalo J L
Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa (Portugal).
Angew Chem Int Ed Engl. 2015 Jan 19;54(4):1172-5. doi: 10.1002/anie.201409344. Epub 2014 Dec 4.
We demonstrate that Ru(II)(CO)2-protein complexes, formed by the reaction of the hydrolytic decomposition products of [fac-RuCl(κ(2)-H2NCH2CO2)(CO)3] (CORM-3) with histidine residues exposed on the surface of proteins, spontaneously release CO in aqueous solution, cells, and mice. CO release was detected by mass spectrometry (MS) and confocal microscopy using a CO-responsive turn-on fluorescent probe. These findings support our hypothesis that plasma proteins act as CO carriers after in vivo administration of CORM-3. CO released from a synthetic bovine serum albumin (BSA)-Ru(II)(CO)2 complex leads to downregulation of the cytokines interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF)-α in cancer cells. Finally, administration of BSA-Ru(II)(CO)2 in mice bearing a colon carcinoma tumor results in enhanced CO accumulation at the tumor. Our data suggest the use of Ru(II)(CO)2-protein complexes as viable alternatives for the safe and spatially controlled delivery of therapeutic CO in vivo.
我们证明,[fac-RuCl(κ(2)-H2NCH2CO2)(CO)3](CORM-3)的水解分解产物与蛋白质表面暴露的组氨酸残基反应形成的Ru(II)(CO)2-蛋白质复合物,能在水溶液、细胞和小鼠体内自发释放CO。通过质谱(MS)和使用CO响应开启荧光探针的共聚焦显微镜检测到了CO的释放。这些发现支持了我们的假设,即体内给予CORM-3后,血浆蛋白可作为CO载体。从合成牛血清白蛋白(BSA)-Ru(II)(CO)2复合物释放的CO导致癌细胞中细胞因子白细胞介素(IL)-6、IL-10和肿瘤坏死因子(TNF)-α的下调。最后,在患有结肠癌肿瘤的小鼠中给予BSA-Ru(II)(CO)2会导致肿瘤处CO积累增加。我们的数据表明,Ru(II)(CO)2-蛋白质复合物可作为体内安全且空间可控地递送治疗性CO的可行替代物。